Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks - Reuters
Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxOV0dqMWtESjYyck5UMktyX3E1S3Q4cWVHR2UtZWVKYmpHLW0xREpuWThOOUFtcVcwMGx6ZG9nOG14MXBBQmVTOFl4T0V4XzkzU3ZMSlhJd2VpeWNFU1pGWXJGZTkxelRMcGl5Wko0cjc5TkhrUm5PUnBVNVdwUTRRc0FyY1dqVDZHQXhFZWV1U243UjlUSXBsajVFeVh5XzJpM1lXMGlwNld1RkdaWk9RUHRyQ0hmOWE3dU5yZlVZUDN0Y0VWSU1hREJwYUVpMVdHSHJqWGV0YTRrNkJPbWptNXdscnZLdw?oc=5" target="_blank">Lilly finds impurity in compounded version of its weight-loss drug, warns of health risks</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters
July 9, 2026 at 12:23 PMSouth African regulators issue recall of Ozempic copies - Reuters
South African regulators issue recall of Ozempic copies Reuters
July 9, 2026 at 09:14 PMUS FDA urges infant-formula makers to tighten supplier oversight after product recalls, botulism outbreaks - Reuters
US FDA urges infant-formula makers to tighten supplier oversight after product recalls, botulism outbreaks Reuters
July 13, 2026 at 06:53 PMUS FDA approves Celcuity's breast cancer drug - Reuters
US FDA approves Celcuity's breast cancer drug Reuters
July 14, 2026 at 10:36 PMIndia's Dr Reddy's delays semaglutide supply, loses $678 mln in market value - Reuters
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value Reuters
July 9, 2026 at 04:54 AMUS FDA approves Vera's kidney disease drug - Reuters
US FDA approves Vera's kidney disease drug Reuters
July 7, 2026 at 05:09 PM